Message from Anna. At least Anna has answered each and every mail that I have sent . It's something.
Thank you for your email.
The transaction with BioTime and BAC has not closed.
During 2013, we expect to have data from the ongoing investigator-sponsored study of imetelstat in patients with myelofibrosis being conducted at the Mayo Clinic, and plans for possible further development of the drug in hematologic malignancies. We also expect to present the full sub-group analysis of the non-small cell lung cancer Ph2 based on tumor telomere length and plan to define a potential strategy for development in solid tumors with short telomeres.
I am sure you have seen it, but I have attached a copy of our investor presentation for additional perusal while Sorry you are stuck indoors during the cold weather.
Anna Krassowska, Ph.D. | Investor and Media Relations
Geron Corporation | 149 Commonwealth Drive | Menlo Park, CA
Sent: Wednesday, February 13, 2013 10:37 AM
Subject: Little to no news as of late ?
Dear Anna , I'm well aware that Geron rarely ever speaks positively about the company. In light of the lofty bonus's given out for what shareholders view as under performance now might be the time to release any positive news? Stem cell companies throughout the world have been receiving great press . The stocks of many have been rising consistently on positive new break through treatments.
Can you tell me if our past stem cell research deal with BTX ( that was given away for next to nothing ) has been completed?
I would appreciate your feedback as most shareholders felt Mr.
Scarlett was brought in to sell the company. The time to sell would have been when we still owned the stem cell side of the business. Now it would appear we have very little to look forward to over the balance of 2013.
Please enjoy sunny California as it is very cold and snowy in New Jersey
Depressed GERN shareholder
black liberal marango , I appreciate the fact that Anna has never failed to respond to my mail. Yes , she has never provided me with any news that we are not aware of. I can only hope that when she reads our messages she can feel the despair shareholders of GERN are feeling. GERN also needs to hear from us with regard to the lofty bonuses handed out for incompetence Who knows , she might just pass a few of our messages up the ladder to scarlett.
Now mango as for yourself you can't afford to buy GERN , and have never held a position . After all our stock is selling for a $1.50 not .07 cents like the only stock you are able to afford ACTC. That food stamp money only spreads so far. Now scurry back into your rat hole and stop bashing GERN